Approvals/TGA/LEAH drospirenone 3mg / ethinylestradiol 20 micrograms (as betadex clathrate) tablet blister pack

Approved

STANDARD

LEAH drospirenone 3mg / ethinylestradiol 20 micrograms (as betadex clathrate) tablet blister pack

Bayer Australia Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: c90402228d500d67
Product Name: LEAH drospirenone 3mg / ethinylestradiol 20 micrograms (as betadex clathrate) tablet blister pack
Artg Id: 226242
Artg Name: LEAH drospirenone 3mg / ethinylestradiol 20 micrograms (as betadex clathrate) tablet blister pack
Sponsor: Bayer Australia Ltd
Company Detail Path: /organization/bayer-australia-ltd
Artg Date: 2014-08-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

c90402228d500d67

Type

Standard